Evidence map›Paper›PMID 35894211›Full record

ArticleeLife2022

Distinct elongation stalls during translation are linked with distinct pathways for mRNA degradation.

Anthony J Veltri, Karole N D'Orazio, Laura N Lessen, Raphael Loll-Krippleber, Grant W Brown, Rachel Green

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. RiboScreenBiomedicines · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Anthony J VeltriDepartment of Molecular Biology and Genetics, Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, United States.ORCID 0000-0002-7067-1796
Karole N D'OrazioDepartment of Molecular Biology and Genetics, Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, United States.
Laura N LessenDepartment of Molecular Biology and Genetics, Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, United States.
Raphael Loll-KrippleberDepartment of Biochemistry and Donnelly Centre, University of Toronto, Toronto, Canada.
Grant W BrownDepartment of Biochemistry and Donnelly Centre, University of Toronto, Toronto, Canada.ORCID 0000-0002-9002-5003
Rachel GreenDepartment of Molecular Biology and Genetics, Howard Hughes Medical Institute, Johns Hopkins University School of Medicine, Baltimore, United States.ORCID 0000-0001-9337-2003
Howard Hughes Medical Institute · USUniversity of Toronto · CA

Funding

BIOCHEMISTRY, CELLULAR AND MOLECULAR BIOLOGY PROGRAMT32GM007445 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI GREEN, RACHEL · 1985 to 2021
$24.1M
PROGRAM IN MOLECULAR BIOPHYSICST32GM008403 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI BARRICK, DOUGLAS E. · 1990 to 2019
$13.5M
Program of Molecular BiophysicsT32GM135131 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI Karen G. Fleming · 2020 to 2026
$5.4M
Molecular mechanisms of ribosome pausing and the cellular responseR37GM059425 · NIGMS · JOHNS HOPKINS UNIVERSITY · PI GREEN, RACHEL · 2014 to 2023
$3.5M
NIGMS NIH HHS R37 GM059425NIGMS NIH HHS T32 GM007445NIGMS NIH HHS T32 GM135131
6 · The paper itself

Abstract

Key protein adapters couple translation to mRNA decay on specific classes of problematic mRNAs in eukaryotes. Slow decoding on non-optimal codons leads to codon-optimality-mediated decay (COMD) and prolonged arrest at stall sites leads to no-go decay (NGD). The identities of the decay factors underlying these processes and the mechanisms by which they respond to translational distress remain open areas of investigation. We use carefully designed reporter mRNAs to perform genetic screens and functional assays in

Indexed as

Saccharomyces cerevisiae ProteinsCodonIntracellular Signaling Peptides and ProteinsProtein BiosynthesisRNA, MessengerRNA StabilitySaccharomyces cerevisiaeTranscription FactorsUbiquitin-Protein LigasesVesicular Transport ProteinsCodonHel2 protein, S cerevisiaeIntracellular Signaling Peptides and ProteinsMyr1 protein, S cerevisiaeNOT5 protein, S cerevisiaeRNA, MessengerSaccharomyces cerevisiae ProteinsSMY2 protein, S cerevisiaeTranscription FactorsUbiquitin-Protein LigasesVesicular Transport Proteinscell biologycodon-optimality-mediated decaygeneticsgenomicsmRNA decayno-go decayquality controlS. cerevisiaeSYH1translation

Identifiers

PMID35894211
PMCPMC9352352
OpenAlexW4288050624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.